EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, wh...
Publications
2 shownPhase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
Purpose This phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast c...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 1,453
- Institution
- Centre Hospitalier Universitaire de Liège
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.